Updated:
Evonik Venture Capital
Evonik Venture Capital was established in 2012 as the dedicated venture arm of Evonik Industries. It replaced the earlier Evonik Corporate Venturing program...
Evonik Venture Capital
Evonik Venture Capital was established in 2012 as the dedicated venture arm of Evonik Industries. It replaced the earlier Evonik Corporate Venturing program and operates from Hanau, Germany. The firm targets early-stage and growth rounds in chemicals, biotechnology and renewable energy. It takes direct positions and limited-partner commitments, including Pangaea Ventures Fund III and Richland Capital. Confirmed holdings include Abolis Biotechnologies in France, Strohm in the Netherlands, Citrine Informatics in the United States and In Ovo in the Netherlands. Two exits have been recorded: Synoste and JeNaCell. The unit participates in industry associations including the German Venture Capital Association and the National Venture Capital Association. No headcount or additional offices are disclosed. No operational events from the last 24 months appear in available records. Governance flows through the parent Evonik Industries AG, which is controlled by the RAG-Stiftung foundation. All investment decisions align with the parent's strategic focus on specialty materials and sustainability targets.
General information
Firm type
Venture Capital
Year founded
2012
Location
Region
Europe
Country
Germany
City
Hanau
Corporate office
Rodenbacher Chaussee 4, 63457 Hanau, Germany
Sector focus
Frequently asked questions
Who runs investment decisions at Evonik Venture Capital?
No named investment committee or lead principals are disclosed in public records. Decisions align with Evonik Industries strategy.
Does Evonik Venture Capital participate in fund commitments or only direct deals?
The firm makes both direct investments and limited-partner commitments. Holdings include Pangaea Ventures Fund III and Richland Capital.
What investment stages does Evonik Venture Capital typically target?
The firm focuses on early-stage seed and start-up rounds as well as expansion and growth rounds.
Which sectors does Evonik Venture Capital explicitly prioritize?
Priority areas include chemicals, biotechnology, renewable energy, materials and agribusiness.
How is Evonik Venture Capital related to Evonik Industries AG?
Evonik Venture Capital is the venture capital arm of Evonik Industries AG and receives its capital allocation from the parent.
Where does the underlying capital come from?
Capital originates from Evonik Industries AG, which is controlled by the RAG-Stiftung foundation.
Does Evonik Venture Capital maintain philanthropic structures?
The related Evonik Foundation supports education and research in chemistry but operates separately from the venture unit.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: